Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01146834 · MORE INFO

Limitations, agreements, and source contact

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma · Source last updated 2019-12-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Arm B: VELCADE \& G-CSF was closed to further enrollment due to futility in 2013. Arm C: CYCLOPHOSPHAMIDE \& G-CSF was closed in 2015 due to futility. Early termination of Arm B and Arm C will limit the sample size for those treatment arms.
point Of Contact
email
run9001@med.cornell.edu
organization
Weill Cornell Medicine
phone
646-962-9376
title
Ruben Niesvizky, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Arm B: VELCADE \& G-CSF was closed to further enrollment due to futility in 2013. Arm C: CYCLOPHOSPHAMIDE \& G-CSF was closed in 2015 due to futility. Early termination of Arm B and Arm C will limit the sample size for those treatment arms.
point Of Contact
email
run9001@med.cornell.edu
organization
Weill Cornell Medicine
phone
646-962-9376
title
Ruben Niesvizky, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice